Methodological requirements for clinical trials in refractory epilepsies — our experience with zonisamide
Authors:
- Yagi KazuichiYKYagi Kazuichi
- Seino MasakazuSMSeino Masakazu
- 1 January 1992
- journal article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 16 (1) , 79-85
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Guidelines for Clinical Evaluation of Antiepileptic DrugsEpilepsia, 1989
- Pilot Study of Zonisamide (1,2‐Benzisoxazole‐3‐methanesulfonamide) in Patients with Refractory Partial SeizuresEpilepsia, 1985
- Proposal for Revised Clinical and Electroencephalographic Classification of Epileptic SeizuresEpilepsia, 1981
- Studies on 3-substituted 1,2-benzisoxazole derivatives. 6. Syntheses of 3-(sulfamoylmethyl)-1,2-benzisoxazole derivatives and their anticonvulsant activitiesJournal of Medicinal Chemistry, 1979